Capricornia’s smart road to A$4.74 million Chinese joint venture
Australian scleral lens manufacturer Capricornia Contact Lens has signed a A$4.74 million joint venture with Chinese ophthalmic products distributor, Guangzhou Ruitai Biotech Co., Ltd. The two companies will establish EPICON (Chengdu) Medical Technology Co., Ltd in Chengdu, China. ‘Through the hard work over the past three and a half years, the accelerated registration of the first Rigid Gas Permeable scleral lens in China via the Real World data program was achieved. This is a remarkable milestone for both Capricornia and Ruitai,’ says Tony Capitano, Managing Director, Capricornia Contact Lens. ‘EPICON will focus on the R&D and manufacturing of scleral lens and other ophthalmic products,’ says Yongliang Lin, founder of Guangzhou Ruitai. ‘It will provide a whole set of innovative solutions in areas related to adolescent myopia, ocular surface diseases, refractive correction, and contact lens care products.’ A fast-tracked journey to China Founded in 1985, Brisbane-based Capricornia Contact Lens manufactured its first scleral lens in 1994. It is one of the earliest manufacturers of scleral lens in the world. The firm’s designs include lenses for Orthokeratology, irregular corneas and specifically the treatment of Keratoconus. Capricornia also manufactures a comprehensive range of custom soft and rigid gas-permeable lenses using state-of-the-art computer-controlled lathes. Guangzhou Ruitai Biotech is a high-tech enterprise focused on research and development, manufacturing, and sales of ophthalmic medical devices. Committed to the ophthalmic industry, Guangzhou Ruitai has invested in ocular surface repair, the prevention and control of adolescent myopia, and the treatment of glaucoma. Many of the company’s ophthalmic products enjoy the largest market share in their respective segments. In June 2019, Austrade Shenzhen introduced Guangzhou Ruitai to Capricornia. This came after China’s State Council released a policy allowing the Hainan provincial government to directly approve the import of certain medical devices that were not previously registered and approved by […]